Someone I have researched on the biotechnological company of Genentech is Robert A. Swanson. He co-founded the company of Genentech in 1976 with Dr. Herbert Boyer, a biochemist at the University of California at San Francisco. He asked Byer about the possibility of developing biotechnology using recombinant DNA to make useful products. He served diligently as director and as CEO (chief executive officer) until February of 1990, when he became chairmen of the board, a position he rightfully claimed as his prior to his retirement in December of 1996. Because of Swanson's leadership, Genentech provided extensive dispensations that are biologically-based such as human insulin, interferons, HGH (Human Growth Hormone), and thrombolytic agents. Before forming Genentech, he was a partner with Kleiner & Perkins venture capital in San Francisco and he was also an investment officer with Citicorp. He formed the K&E Management, a private investment management firm. Swanson earned his Bachelor of Science in Chemistry from MIT (Massachusetts Institute of Technology and Master of Science in Management from MIT's Sloan School of Management. He was on the Committee of the Overseers' Visiting Committee of the Harvard Medical School and ministered to the /board of Fellows of the Faculty of Medicine at Harvard University. Also appointed to the Royal Swedish academy of Engineering Sciences. Robert Swanson conduced to numerous civic and cultural activities like being a trustee of the San Francisco Ballet, the Museum of Contemporasry Art, the San Jose Tech Center, and as chairman of the board of Nueva School.
Picture and Link
http://www.gene.com/gene/about/corporate/history/founders.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment